提升皮肤病领域指南和共识质量的策略与建议

doi:10.35541/cjd.20230249

Abstract

Abstract: 【Abstract】 In recent years, the number of guidelines/consensus in the field of dermatology has increased in China, but the quality is variable. This article proposes to describe the specific process of guideline/consensus development in 10 steps, focusing on the initiation phase, advancement phase, as well as dissemination, implementation and update phases, with the aim to improve the quality of guidelines/consensus in the field of dermatology.

Key words: Skin diseases, Benchmarking, Guidelines, Consensus, Quality improvement

Chen Yaolong, Liu Hui, Yao Zhirong, Gao Xinghua. Strategies and suggestions for improving the quality of guidelines and consensus in the field of dermatology[J]. Chinese Journal of Dermatology, 2023, 56(9): 805-808.doi:10.35541/cjd.20230249

References ［36］

［1］	陈耀龙, 罗旭飞, 王吉耀, 等. 如何区分临床实践指南与专家共识［J］. 协和医学杂志, 2019,10（4）:403⁃408. doi: 10.3969/j.issn.1674⁃9081.2019.04.018.
［2］	陈耀龙, 罗旭飞. 临床实践指南的制订方法与步骤［J］. 中华传染病杂志, 2019,37（9）:523⁃526. doi: 10.3760/cma.j.issn. 1000⁃6680.2019.09.003.
［3］	Grilli R, Magrini N, Penna A, et al. Practice guidelines developed by specialty societies: the need for a critical appraisal［J］. Lancet, 2000,355（9198）:103⁃106. doi: 10.1016/S0140⁃6736（99）02171⁃6.
［4］	Chen YL, Wang C, Shang H, et al. Clinical practice guidelines in China［J］. BMJ, 2018,360:j5158. doi: 10.1136/bmj.j5158.
［5］	Chen YL, Yao L, Xiao XJ, et al. Quality assessment of clinical guidelines in China: 1993 - 2010［J］. Chin Med J （Engl）, 2012,125（20）:3660⁃3664.
［6］	Zhang R, Yan SY, Wang YY, et al. Analysis of the status and trends of Chinese clinical practice guideline development between 2010 and 2020: a systematic review［J］. Front Med （Lausanne）, 2021,8:758617. doi: 10.3389/fmed.2021.758617.
［7］	中华医学会杂志社指南与标准研究中心, 中国医学科学院循证评价与指南研究创新单元, 世界卫生组织指南实施与知识转化合作中心. 2021年医学期刊发表中国指南和共识的科学性、透明性和适用性的评级［J］. 中华医学杂志, 2022,102（30）:2319⁃2328. doi: 10.3760/cma.j.cn112137⁃20220602⁃01232.
［8］	王丽, 赵巍. 开启强强战略合作　共促指南质量提升［J］. 中华医学信息导报, 2020,35（21）:12. doi: 10.3760/cma.j.issn.1000⁃8039.2020.21.113.
［9］	杨楠, 赵巍, 潘旸, 等. 针对临床实践指南科学性、透明性和适用性的评级工具研发［J］. 中华医学杂志, 2022,102（30）:2329⁃2337. doi: 10.3760/cma.j.cn112137⁃20220219⁃00340.
［10］	STAR［DB/OL］. （2022⁃07⁃15）［2023⁃07⁃18］. https://www.star⁃guidelines.cn/index.
［11］	王禹毅, 贾瑞玲, 林茂, 等. 2009—2019年中国期刊发表的皮肤疾病临床指南报告质量评价［J］. 中华皮肤科杂志, 2021,54（3）:236⁃241. doi: 10.35541/cjd.20191037.
［12］	陈耀龙, 张静怡, 张天嵩, 等. 指南的系统评价: 是什么, 为什么, 怎么做［J］. 协和医学杂志, 2020,11（3）:320⁃324. doi: 10. 3969/j.issn.1674⁃9081.20200126.
［13］	国际实践指南注册与透明化平台［DB/OL］. （2023⁃07⁃17）［2023⁃07⁃18］. http://www.guidelines⁃registry.cn/guid.
［14］	Xun YQ, Liu H, Meng M, et al. Characteristics of guidelines registered on the PREPARE platform［J］. J Evid Based Med, 2022,15（4）:341⁃346. doi: 10.1111/jebm.12501.
［15］	Xun YQ, Luo XF, Lv M, et al. Protocols for clinical practice guidelines［J］. J Evid Based Med, 2023,16（1）:3⁃9. doi: 10.1111/jebm.12502.
［16］	陈耀龙, 杨克虎, 王小钦, 等. 中国制订/修订临床诊疗指南的指导原则（2022版）［J］. 中华医学杂志, 2022,102（10）:697⁃703. doi: 10.3760/cma.j.cn112137⁃20211228⁃02911.
［17］	中华医学期刊网.中华医学会系列杂志稿约通则（2022版）［EB/OL］. ［2023⁃04⁃03］. https://www.cmaph.org/r/cms/guanwang/ pdf/web/viewer.html?file=/files/u/cms/guanwang/202210/21162751 kzut.pdf
［18］	郭强强, 荀杨芹, 刘辉, 等. 临床实践指南的注册［J］. 协和医学杂志, 2023,14（1）:203⁃208. doi: 10.12290/xhyxzz.2022⁃0521.
［19］	王子君, 罗旭飞, 陈耀龙. 应重视规范撰写指南计划书［J］. 中华心血管病杂志, 2022,50（7）:627⁃629. doi: 10.3760/cma.j.cn112148⁃20220415⁃00273.
［20］	王子君, 史乾灵, 刘云兰, 等. 2019年期刊公开发表的中国临床实践指南文献调查与评价——制订人员及工作组情况［J］. 协和医学杂志, 2021,12（4）:552⁃559. doi: 10.12290/xhyxzz.2021⁃0438.
［21］	陈耀龙, 王健健, 詹思延, 等. 如何应对指南制订中的利益冲突［J］. 协和医学杂志, 2019,10（6）:685⁃691. doi: 10.3969/j.issn.1674⁃9081.2019.06.023.
［22］	史乾灵, 王子君, 马艳芳, 等. 2019年期刊公开发表的中国临床实践指南文献调查与评价——资助与利益冲突［J］. 协和医学杂志, 2021,12（5）:784⁃790. doi: 10.12290/xhyxzz.2021⁃0541.
［23］	Checketts JX, Sims MT, Vassar M. Evaluating industry payments among dermatology clinical practice guidelines authors［J］. JAMA Dermatol, 2017,153（12）:1229⁃1235. doi: 10.1001/jamadermatol.2017.3109.
［24］	Freeman EE, McMahon DE, Fitzgerald M, et al. Modernizing clinical practice guidelines for the American Academy of Dermatology［J］. J Am Acad Dermatol, 2020,82（6）:1487⁃1489. doi: 10.1016/j.jaad.2019.12.075.
［25］	Mohd Mustapa MF, Exton LS, Bell HK, et al. Updated guidance for writing a British Association of Dermatologists clinical guideline: the adoption of the GRADE methodology 2016［J］. Br J Dermatol, 2017,176（1）:44⁃51. doi: 10.1111/bjd.15201.
［26］	叶城斌, 邹颖. 不同国家及地区特应性皮炎治疗指南的比较［J］. 中国皮肤性病学杂志, 2020,34（11）:1331⁃1336,1340. doi: 10.13735/j.cjdv.1001⁃7089.202003205.
［27］	中华医学会皮肤性病学分会, 中国医师协会皮肤科医师分会, 中国康复医学会皮肤性病委员会. 中国尖锐湿疣临床诊疗指南（2021完整版）［J］. 中国皮肤性病学杂志, 2021,35（4）:359⁃374. doi: 10.13735/j.cjdv.1001⁃7089.202101183.
［28］	陈耀龙, 李幼平, 杜亮, 等. 医学研究中证据分级和推荐强度的演进［J］. 中国循证医学杂志, 2008,8（2）:127⁃133. doi: 10.3969/j.issn.1672⁃2531.2008.02.012.
［29］	刘海波, 刘芳, 桑红. 在皮肤学科指南中应用GRADE证据质量分级和推荐强度评价系统的意义［J］. 中华皮肤科杂志, 2018,51（9）:639⁃641. doi: 10.3760/cma.j.issn.0412⁃4030.2018. 09.001.
［30］	RIGHT. Extensions of the RIGHT Statement［EB/OL］. （2023⁃01⁃01）［2023⁃07⁃18］. http://www.right⁃statement.org/extensions.
［31］	陈耀龙, 史乾灵, 赵俊强, 等. 从知到行:跨越指南理论与实践的鸿沟［J］. 协和医学杂志, 2020,11（6）:746⁃753. doi: 10.3969/j.issn.1674⁃9081.2020.06.020.
［32］	吕萌, 罗旭飞, 刘云兰, 等. 2019年期刊公开发表的中国临床实践指南文献调查与评价——传播与实施情况［J］. 协和医学杂志, 2022,13（4）:673⁃678. doi: 10.12290/xhyxzz.2022⁃0028.
［33］	靳英辉, 赵志慧, 黄粲然, 等. 临床实践指南实施性评价工具的研制和验证评价［J］. 中国循证医学杂志, 2022,22（1）:111⁃119. doi: 10.7507/1672⁃2531.202106002.
［34］	Martínez García L, Sanabria AJ, García Alvarez E, et al. The validity of recommendations from clinical guidelines: a survival analysis［J］. CMAJ, 2014,186（16）:1211⁃1219. doi: 10.1503/cmaj.140547.
［35］	李思雨, 刁莎, 石雨晴, 等. 指南临床适用性评价工具（2.0版）［J］. 中国循证医学杂志, 2023,23（5）:597⁃605. doi: 10.7507/1672⁃2531.202207136.
［36］	陈耀龙, 杨克虎. 正确理解、制订和使用临床实践指南［J］. 协和医学杂志, 2018,9（4）:367⁃373. doi: 10.3969/j.issn.1674⁃9081.2018.04.015.

[1]	Sun Xiaojie, Liu Yi. Anti-androgen drugs in the treatment of skin diseases [J]. Chinese Journal of Dermatology, 2023, 56(9): 882-885.
[2]	Jing Ke, Wang Yuan, Li Suo, Feng Suying. Autoimmune subepidermal bullous diseases characterized by annular erythema and blisters: a retrospective analysis of 25 cases [J]. Chinese Journal of Dermatology, 2023, 56(9): 832-838.
[3]	China Dermatologist Association. Guidance on application of moisturizers and emollients: an expert consensus （2023） [J]. Chinese Journal of Dermatology, 2023, 56(8): 711-717.
[4]	Committee on Psoriasis, Chinese Society of Dermatology. Guideline for the diagnosis and treatment of psoriasis in China （2023 edition） [J]. Chinese Journal of Dermatology, 2023, 56(7): 573-625.
[5]	Chen Qiquan, Yang Xianjie, Gu Heng, Xu Jinhua, Hao Fei, Yao Xu, Song Zhiqiang. Construction of “Expert consensus on diagnosis and treatment of chronic inducible urticaria in China （2023）” based on the Delphi method [J]. Chinese Journal of Dermatology, 2023, 56(6): 534-539.
[6]	Immunology Group, Chinese Society of Dermatology. Expert consensus on diagnosis and treatment of chronic inducible urticaria in China （2023） [J]. Chinese Journal of Dermatology, 2023, 56(6): 479-488.
[7]	Chinese Society of Dermatology, China Dermatologist Association. Expert consensus on treat-to-target in chronic spontaneous urticaria （2023） [J]. Chinese Journal of Dermatology, 2023, 56(6): 489-495.
[8]	Writing Committee Expert Group on “Treatment of mycosis fungoides: a Chinese expert consensus （）”. Treatment of mycosis fungoides: a Chinese expert consensus （2023） [J]. Chinese Journal of Dermatology, 2023, 56(5): 402-409.
[9]	Environmental and Occupational Skin Disease Research Group, Committee on Dermatology, Chinese Association of Integrative Medicine, Committee on Dermatology, Chinese Association of Geriatric Research, Committee on Dermatological Drug Research, The Chinese Association of Traditional Chinese Medicine. Expert consensus on integrated traditional Chinese and Western medicine for eczema and dermatitis [J]. Chinese Journal of Dermatology, 2023, 56(4): 287-293.
[10]	China Dermatologist Association, State Key Laboratory of Complex Severe and Rare Diseases, National Clinical Research Center for Dermatologic and Immunologic Diseases. Consensus on health education of patients with pemphigus （2023） [J]. Chinese Journal of Dermatology, 2023, 0(4): 20230123-e20230123.
[11]	Committee on Psoriasis, Chinese Society of Dermatology. Expert consensus on treat-to-target approach for the treatment of psoriasis with biological agents [J]. Chinese Journal of Dermatology, 2023, 56(3): 191-203.
[12]	Chinese Society of Dermatology, Chinese Association of Rehabilitation Dermatology, Combination of Traditional and Western Medicine Dermatology, The Dermatology Branch of Chinese Medical Education Association. Expert consensus on diagnosis and treatment of senile herpes zoster [J]. Chinese Journal of Dermatology, 2023, 56(2): 97-104.
[13]	Zhang Jiaqi, Wu Fan, Han Yuqing, Liu Qi, Pan Yao. Application of multi-photon microscopy in dermatology [J]. Chinese Journal of Dermatology, 2023, 0(2): 20230022-e20230022.
[14]	Rosacea Research Center, Chinese Society of Dermatology, Rosacea Professional Committee, China Dermatologist Association. Expert consensus on intradermal injections with botulinum toxin A for the treatment of flushing and persistent erythema caused by rosacea [J]. Chinese Journal of Dermatology, 2023, 56(1): 16-21.
[15]	Immunology Group, Chinese Society of Dermatology. Consensus on the whole-process management of atopic dermatitis [J]. Chinese Journal of Dermatology, 2023, 56(1): 5-15.

Strategies and suggestions for improving the quality of guidelines and consensus in the field of dermatology

PDF

PDF (Mobile)

Knowledge

Abstract

Cite this article

share this article

References ［36］

Related Articles 15

Metrics

Comments

Recommended 10